Lung Transplantation (Lung Biology in Health and Disease) de Wickii Vigneswaran

Lung Transplantation: Lung Biology in Health and Disease

Wickii Vigneswaran

Edward Garrity

Once considered an experimental therapy, lung transplantation is now regarded as a viable treatment option for selected patients with end-stage lung diseases. As more and more of these cases arise, it becomes imperative for those involved in the care of lung transplant patients to have a vast understanding of the multidiscipline process of lung transplantation. This text provides a comprehensive overview of this process covering everything from the history of the lung transplant program to the long term effects of the procedure.

Citește tot Restrânge

Din seria Lung Biology in Health and Disease

5%

Preț: 631^.43 lei
5%

Preț: 370^.82 lei
18%

Preț: 1342^.79 lei
5%

Preț: 1681^.87 lei
5%

Preț: 1502^.38 lei
5%

Preț: 1191^.78 lei
17%

Preț: 1134^.00 lei
5%

Preț: 653^.81 lei
5%

Preț: 627^.75 lei
5%

Preț: 661^.16 lei
15%

Preț: 560^.05 lei
5%

Preț: 363^.85 lei
17%

Preț: 382^.88 lei
5%

Preț: 369^.92 lei
5%

Preț: 527^.64 lei
5%

Preț: 527^.64 lei
17%

Preț: 364^.48 lei
15%

Preț: 628^.23 lei
5%

Preț: 2078^.19 lei
5%

Preț: 1421^.95 lei
5%

Preț: 1009^.76 lei
5%

Preț: 1003^.72 lei
5%

Preț: 1416^.68 lei
5%

Preț: 3201^.47 lei
5%

Preț: 2077^.67 lei
18%

Preț: 1432^.92 lei
9%

Preț: 958^.65 lei
18%

Preț: 1100^.99 lei
18%

Preț: 2180^.76 lei
17%

Preț: 1213^.14 lei
5%

Preț: 828^.83 lei
5%

Preț: 1374^.45 lei

Cuprins

Preface Part I General 1. The History of Lung Transplantation 2. Immunology of Lung Transplantation 3. Ethics in Lung Transplantation 4. Structure and Support for Success Part II Pretransplant Evaluation and Management 5. Lung Transplantation for Idiopathic Pulmonary Fibrosis 6. Emphysema and a-1 Antitrypsin Deficiency 7. Cystic Fibrosis and Bronchiectasis 8. Pulmonary Arterial Hypertension 9. Connective Tissue Disorders 10. Patient Selection 11. Recipient Management Pretransplant Part III Donor Management 12. Lung Donor Allocation Systems 13. Donor Management 14. Lung Donor Selection Criteria 15. Non-Heart-Beating Donor: Lung Transplantation with Donation After Cardiac Death (Controlled DCD) Allografts 16. Preservation of the Donor Lung 17. Donor Procurement 18. Ex Vivo Management of Lungs Part IV Recipient Operation 19. Assessment and Management of the Sensitized Patient 20. Anesthesia for Lung Transplantation 21. Single-Lung Transplantation 22. Bilateral Sequential Lung Transplantation: Technical Aspects 23. Heart-Lung Transplantation 24. Lobar Lung Transplantation Part V Post-transplant Care 25. Critical Care Management 26. Primary Graft Dysfunction 27. Managing Surgical Complications 28. ECMO in Lung Transplantation Part VI Early Medical Management 29. Maintenance Immunosuppression in Lung Transplantation 30. Fungal Infections in Lung Transplant 31. Viral Infections 32. Bacterial Infections After Lung Transplantation 33. Post-Transplant Lung Pathology Part VII Late Medical Management and Outcome 34. Bronchiolitis Obliterans Syndrome: Clinical Risk Factors and Pathophysiology 35. Bronchiolitis Obliterans: Diagnosis and Management 36. Malignancy Following Transplantation 37. Lung Transplantation: Chronic Complications and Management 38. Quality of Life After Lung Transplantation Part VIII Future Directions 39. Proteomics, Genomics, and Lung Transplantation 40. Immune Tolerance 41. Augmentation of Maintenance Immunosuppression in Lung Transplantation 42. Artificial Lung: A New Inspiration

Descriere